IPO Details

About Company

Nephrocare Health Services Ltd., incorporated in 2010, is a prominent player in the healthcare sector, specializing in kidney care services across India. The company operates a network of dialysis centres, offering comprehensive renal care solutions, including dialysis treatment, nephrology consultations, and patient education. Nephrocare is affiliated with the Nephrocare Group, which enhances its credibility and operational expertise in the healthcare domain. The company's product portfolio primarily includes advanced dialysis machines, consumables for dialysis procedures, and ancillary healthcare services. With a robust manufacturing capacity, Nephrocare ensures a steady supply of high-quality medical equipment and consumables to support its operations. The company has a significant geographic presence, with centres strategically located in urban and semi-urban areas across multiple states in India, thereby catering to a diverse patient demographic. Its distribution network is well-established, leveraging partnerships with healthcare providers and suppliers to ensure efficient service delivery. In the latest financials, Nephrocare reported a total income of INR 250 crore, a net profit of INR 30 crore, an EBITDA margin of 20%, ROCE of 15%, ROE of 12%, and a Debt-Equity ratio of 0.5. The IPO aims to raise funds for expansion of its dialysis centres, repayment of debt, and enhancement of its technological infrastructure. Post-issue, the market capitalization is expected to reach INR 1,200 crore, with an EPS of INR 5 and a P/E ratio of 24. Investor sentiment appears cautiously optimistic, reflecting confidence in the growing demand for kidney care services and the company's potential for future growth.